Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-067082
Filing Date
2023-06-01
Accepted
2023-06-01 16:33:19
Documents
1
Period of Report
2023-06-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2317472-12_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2317472-12_4seq1.xml 4 16691
  Complete submission text file 0001104659-23-067082.txt   18040
Mailing Address 2525 28TH STREET SUITE 200 BOULDER CO 80301
Business Address
Allen Andrew R (Reporting) CIK: 0001374539 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38811 | Film No.: 23985214

Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Issuer) CIK: 0001750019 (see all company filings)

EIN.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)